MEYER ANDREW HOLLMAN

PrivateCIK: 1864159
Location

LA JOLLA, CA

MEYER ANDREW HOLLMAN (Chief Business Officer) sold 16.9% of their position (16.66K shares) of JANUX THERAPEUTICS, INC. on the open market

Open‑market sale worth $501.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderMEYER ANDREW HOLLMANCIK 1864159
IssuerJANUX THERAPEUTICS, INC.CIK 1817713
Officer· Chief Business Officer
Since Jun 2021
-16.66K
Net shares
Net seller
$501.0K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
16.66K acquired · 33.33K disposed
Non-Derivative Transactions3

Common Stock

Direct
M · Option Exercise

Shares

+10K

Price / share

$4.21

Trade value

$42.10K

% of position

12.2%
10/28/2025
82.14K92.14K

Common Stock

Direct
M · Option Exercise

Shares

+6.67K

Price / share

$10.59

Trade value

$70.59K

% of position

7.2%
10/28/2025
92.14K98.80K

Common Stock

Direct
S · Sale

Shares

16.66K

Price / share

$30.06

Trade value

$500.99K

% of position

16.9%
10/28/2025
98.80K82.14K
Total

Net shares

+0.00

Net value

-$388.30K

Derivative Transactions2

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

10K shares

Shares

10K

Strike price

4.21

Held after

77.33K

Exercisable

10/28/2025

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

6.67K shares

Shares

6.67K

Strike price

10.59

Held after

121.43K

Exercisable

10/28/2025
MEYER ANDREW HOLLMAN — Insider Transaction (Form 4) Filed Oct 30, 2025 | Finecho